Learn about VUMERITY

VUMERITY could lead to fewer relapses

In clinical trials, dimethyl fumarate—which has the same active metabolite as VUMERITY® (diroximel fumarate)—was shown to work against relapsing multiple sclerosis (MS). A metabolite is part of the medication that remains after the drug has been processed (or metabolized) in the body.

Learn about the potential benefits and risks of VUMERITY, and get tools and tips to help you have a productive conversation with your healthcare provider.

VUMERITY effectiveness

Find out more about clinical trials.

See results

Learn about the potential side effects of VUMERITY.

Learn about safety
Discussing VUMERITY

Download questions and materials to take to your next appointment.

More info

We also recommend